Aptar expands US production of AAT aerosol valve for high-powder formulations
The valve’s stem design minimizes clogging and improves spray consistency, while local manufacturing in Illinois reduces lead times.
See the latest news and media coverage for Aptar. We track all announcements, press releases, and industry mentions in real time, all in one place.
Drug and consumer product dosing, dispensing and protection technologies
aptar.comLast updated
In short: Aptar announced that Gael Touya will succeed Stephan Tanda as CEO, reported mixed Q1 2026 financial results, and secured several technology patents.
The valve’s stem design minimizes clogging and improves spray consistency, while local manufacturing in Illinois reduces lead times.
The report details environmental and social performance, including climate transition plans and independent assurance.
The first-of-its-kind packaging-delivered approach addresses nitrosamine risk in pharmaceuticals.
The program aims to enable inhaled and nasal delivery of GLP-1 therapies using spray-dried and powder processing.
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an...
Aptar Midland broke ground May 7 on an 8,600-square-foot, $1 million-plus expansion of its facility. The facility is currently 35,000 square feet, with about 11,000...
The company that turned the condiment world upside-down is now turning drug delivery on its nose at the same time it elevates its pharmaceutical leader...
The injectables division delivered another quarter of strong, double-digit growth. Consumer dispensing also contributed positively, with volume growth across Beauty and Closures, supported by robust...
Track Aptar and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Aptar and other trending companies.